Splice Bio - Gilde Healthcare

Splice Bio

Barcelona, Spain
Gene Therapy
Since: 2022

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.

More Splice Bio news

Gilde Healthcare company SpliceBio enters $216 million Gene Therapy collaboration with Spark Therapeutics

Gilde Healthcare invests in Eur 50M series A round of Spanish Gene Therapy company SpliceBio